| CAS No 98440-50-7 |
1-(2-amino-5-morpholinophenyl)-1-ethanonenull |
Inquiry |
| CAS No 98022-43-6 |
5-Amino-3-methoxy-1,2,4-thiadiazolenull |
Inquiry |
| CAS No 97936-44-2 |
2-[(4-chlorophenyl)thio]pyridine-3-carbonyl chloridenull |
Inquiry |
| CAS No 97316-55-7 |
ethyl 3-cyano-2-pyridinecarboxylatenull |
Inquiry |
| CAS No 97316-50-2 |
ethyl 4-cyano-2-pyridinecarboxylatenull |
Inquiry |
| CAS No 97136-93-1 |
5-(benzylthio)-4-bromo-2-phenylpyridazin-3(2H)-onenull |
Inquiry |
| CAS No 97051-69-9 |
N1-[2-Amino-4-(Trifluoromethyl)Phenyl]Acetamidenull |
Inquiry |
| CAS No 96965-79-6 |
3,6-Dibromo-2,7-dihydroxynaphthalenenull |
Inquiry |
| CAS No 96722-61-1 |
Ethyl 2-chloro-2-[2-(3,5-dichlorophenyl)hydrazono]null |
Inquiry |
| CAS No 96623-75-5 |
1-(2-fluoro-5-nitrophenyl)-1H-pyrrolenull |
Inquiry |
| CAS No 96428-16-9 |
8-(benzyloxy)imidazo[1,2-a]pyridinenull |
Inquiry |
| CAS No 964-42-1 |
1,3-diphenyl-1H-pyrazole-5-carboxylic acidnull |
Inquiry |
| CAS No 96220-15-4 |
3-(4-Ethylphenyl)-3-oxopropanenitrilenull |
Inquiry |
| CAS No 96017-23-1 |
4-chloro-2-methyl-5-(1-methylhydrazino)-2,3-dihydropyridazin-3-onenull |
Inquiry |
| CAS No 96017-10-6 |
2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanoic acidnull |
Inquiry |
| CAS No 957-13-1 |
Hexamethoxyphosphazinenull |
Inquiry |
| CAS No 95631-62-2 |
1-Bromo-1-Ethoxycyclopropanenull |
Inquiry |
| CAS No 95629-02-0 |
Ethyl 3-bromo-4-oxo-piperidine-1-carboxylatenull |
Inquiry |
| CAS No 95611-88-4 |
5-(4-Chloro-2-nitro-phenyl)-furan-2-carboxylicnull |
Inquiry |
| CAS No 955-54-4 |
2-[(4-chlorophenyl)thio]nicotinic acidnull |
Inquiry |
| CAS No 955-03-3 |
2,6-Di-(tert-butyl)-4-nitrosophenolnull |
Inquiry |
| CAS No 95337-69-2 |
1-[1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2,2,2-trifluoro-1-ethanonenull |
Inquiry |
| CAS No 95095-46-8 |
2,3-diamino-5-bromo-6-(trifluoromethyl)-4(3H)-pyrimidinonenull |
Inquiry |
| CAS No 95061-68-0 |
(1-Hydroxyallyl)trimethylsilanenull |
Inquiry |
| CAS No 94692-05-4 |
ethyl 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxylatenull |
Inquiry |
